Morgan Stanley initiated Health Management Associates HMA with an Underweight rating.
Morgan Stanley commented, "We think HMA is well positioned to benefit from healthcare reform and has manageable exposure to potential cuts being discussed as part of the deficit debate. However, we have a lower earnings trajectory for HMA through 2016 with a CAGR of 7.8% versus 9.1% on average for the other names after accounting for HCIT payments.Continued overhang from “60 Minutes” segment and related government investigations, which we think may weigh on admissions and multiples."
Health Management Associates closed at $9.51 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in